TY - BOOK ID - 8577012 TI - Drug-like properties : concepts, structure design and methods from ADME to toxicity optimization AU - Di, Li AU - Kerns, Edward H. PY - 2016 SN - 0128013222 0128010762 9780128010761 9780128013229 PB - Oxford : Academic Press, DB - UniCat KW - Pharmaceutical chemistry. KW - Drugs KW - Drug development. KW - Structure-activity relationships. KW - Design. KW - Drug Design KW - Drug Evaluation, Preclinical KW - Drug-Related Side Effects and Adverse Reactions KW - Pharmaceutical Preparations KW - Pharmacokinetics KW - Structure-Activity Relationship KW - Drug design KW - Pharmaceutical design KW - Drug development KW - Development of drugs KW - New drug development KW - Pharmacology KW - Pharmacy KW - Structure-activity relationship (Pharmacology) KW - Pharmaceutical chemistry KW - Structure-activity relationships (Biochemistry) KW - Chemistry, Medical and pharmaceutical KW - Chemistry, Pharmaceutical KW - Drug chemistry KW - Medical chemistry KW - Medicinal chemistry KW - Pharmacochemistry KW - Chemistry KW - Development UR - https://www.unicat.be/uniCat?func=search&query=sysid:8577012 AB - Outside back cover : "Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, only a fraction have sufficient ADME (absorption, distribution, metabolism, elimination) properties, and acceptable toxicology properties, to become a drug product that will successfully complete human Phase I clinical trials. Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, Second Edition, provides scientists and students the background and tools to understand, discover, and develop optimal clinical candidates. This valuable resource explores physiochemical properties, including solubility and permeability, before exploring how compounds are absorbed, distributed, and metabolized safely and stably. Review chapters provide context and underscore the importance of key concepts such as pharmacokinetics, toxicity, the blood-brain barrier, diagnosing drug limitations, prodrugs, and formulation. Building on those foundations, this thoroughly updated revision covers a wide variety of current methods for the screening (high throughput), diagnosis (medium throughput) and in-depth (low throughput) analysis of drug properties for process and product improvement. From conducting key assays for interpretation and structural analysis, the reader learns to implement modification methods and improve each ADME property. Through valuable case studies, structure-property relationship descriptions, and structure modification strategies, Drug-Like Properties, Second Edition, offers tools and methods for ADME/Tox scientists through all aspects of drug research, discovery, design, development, and optimization.Provides a comprehensive and valuable working handbook for scientists and students in medicinal chemistry. Includes expanded coverage of pharmacokinetics fundamentals and effects. Contains updates throughout, including the authors’ recent work in the importance of solubility in drug development; new and currently used property methods, with a reduction of seldom-used methods; and exploration of computational modeling methods" ER -